Abstracts (HTML) List of Authors

Cai, C

How endoglin modulates the hepatocytes' response to BMP-9
Characterization of the liver phenotype of the BMP-9 knock-out mouse
Pro- and anti-tumourigenic effects of Bone morphogenetic protein 9 signaling in hepatocellular carcinoma
IL-22 and IL22-binding protein are associated with development of and mortality from acute-on-chronic liver failure (ACLF)

Cai, J

The journey of a patient with biopsy-proven non-alcoholic steatohepatitis (NASH) – results from a real-world study

Calvisi, DF

Protumorigenic stathmin expression in liver cancer is linked to karyopherin alpha 2-dependent import of E2F1 and TFDP1
Loss of Axin1 induced hepatocarcinogenesis requires intact β-Catenin but not Notch cascade in mice
Proteomic analysis of clear cell foci in the human liver identifies differential expression of Starch-Binding Domain-Containing Protein 1 (STBD1)
The interaction of Serum Response Factor (SRF) and ETS domain transcription factors regulate the transcription of the MDM 4 oncogene in HCC
MEK inhibition suppresses cholangiocarcinoma growth by restraining tumor cell proliferation and modulating tumor microenvironment

Canbay, A

Low free triiodothyronine (fT3) is associated with advanced fibrosis in non-alcoholic steatohepatitis (NASH)
Auswirkung einer Binge Eating Episode auf Leberschädigung, den Gallensäuremetabolismus und Zelltodmarker
Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis
Cholangiozyten haben eine phagozytische Funktion und zeigen darunter erhöhte metabolische Aktivität und Proliferationsraten

Cantz, T

Functional microRNA screening to improve hepatocyte formation via direct reprogramming

Carambia, A

Monocytes as a potential trigger of Th17-differentiation in primary sclerosing cholangitis (PSC)

Caruso, S

miR-193a-5 p regulates NUSAP1 expression to suppress hepatocarcinogenesis

Casey, J

Differential response of culture-derived HDV-1 and HDV-3 strains to peg-IFNα treatment in human liver chimeric mice despite strong ISG induction

Casillas, R

Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV

Casper, M

Protektiver Effekt von Statinen auf die Entstehung der heptischen Enzephalopathie ist abhängig von häufigen Genvarianten
Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis
The ATG16L1 Gene Variant rs2241880 (p.T300A) Is Associated With Susceptibility to HCC In Patients with Cirrhosis

Castven, D

Exploring molecular basis of therapy response in patient derived primary liver cancer cell lines
Landscape of (epi-)genetic alterations during malignant transformation in liver cancer
Differential effect of TGF-β family members on proliferation and migration in primary liver cancer

Chalmers, J

Spleen to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications

Chamulitrat, W

iPLA2b Deficiency Exacerbates an Increase of Bile Acids in the Enterohepatic Circulation by Downregulating Hepatic FXR in Mice fed with Methionine-choline-deficient Diet
Phospho- and sphingolipid metabolism is altered in hereditary hemochromatosis independent of iron content and PNPLA3 polymorphism
Liver specific-deletion of FATP4 increases hepatic triglycerides upon D8-glycerol administration: a stable isotope labelling study
iPLA2beta Deficiency in mice fed methionine-choline-deficient diet does not protect hepatic steatosis but still attenuates hepatic fatty acids, cholesterol esters, and liver enzymes
Externalization of phosphatidylethanolamine in hepatocytes from male mice is increased by iPLA2β deficiency associated with cellular oxidative stress

Chatzigeorgiou, A

The role of Formyl Peptide Receptor 1 in the development of non-alcoholic steatohepatitis

Chavakis, T

The role of Formyl Peptide Receptor 1 in the development of non-alcoholic steatohepatitis
The RNA binding protein HuR is a master regulator of hepatic-lipid homeostasis

Che, L

Loss of Axin1 induced hepatocarcinogenesis requires intact β-Catenin but not Notch cascade in mice
MEK inhibition suppresses cholangiocarcinoma growth by restraining tumor cell proliferation and modulating tumor microenvironment

Chen, C

c-MYC overexpression in hepatocytes is associated with spontaneous development of non-alcoholic steatohepatitis (NASH) in mice

Chen, LS

The role of Formyl Peptide Receptor 1 in the development of non-alcoholic steatohepatitis

Chen, W

ECM1 is a gatekeeper that restrains TGF-β activation to maintain liver homeostasis and prevent fibrogenesis

Chen, X

Loss of Axin1 induced hepatocarcinogenesis requires intact β-Catenin but not Notch cascade in mice
MEK inhibition suppresses cholangiocarcinoma growth by restraining tumor cell proliferation and modulating tumor microenvironment

Cheng, X

Site-specific Smad3 linker region phosphorylation as a marker in cholangiocarcinoma

Cheng, Y

iPLA2beta Deficiency in mice fed methionine-choline-deficient diet does not protect hepatic steatosis but still attenuates hepatic fatty acids, cholesterol esters, and liver enzymes

Christ, B

Physical contact between mesenchymal stromal cells and hepatocytes via tunneling nanotubes favor the utilization of hepatocyte lipids
Verification of 3D liver organoids from cholangiocarcinoma tissue for chemotherapeutic drug screening
Metabolische Wirkungen mesenchymaler Stromalzellen in der nicht-alkoholischen Steatohepatitis

Christen, U

Hepatocellular autotaxin is a major source of systemic lysophosphatidic acid and regulates glucose homeostasis

Christiansen, N

Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Christidis, G

Altered Fgf21 response in alcohol induced “Acute-on-chronic liver injury” (ACLI) model

Chung, KJ

The RNA binding protein HuR is a master regulator of hepatic-lipid homeostasis

Churin, Y

CB1 knockout alleviates hepatic steatosis via lipophagy and lipolysis in HBs transgenic mice
Hepatozelluläre c-Jun Aktivierung durch Schistosoma mansoni Infektion im Hamster Modell und primären humanen Hepatozyten
Ausschalten der Typ I Interferonantwort führt zu verminderter Induktion von Autophagie in HBs transgenen Mäusen

Ciesek, S

Impaired adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure

Cigliano, A

Proteomic analysis of clear cell foci in the human liver identifies differential expression of Starch-Binding Domain-Containing Protein 1 (STBD1)

Claria, J

Compartmentalization of immune response and microbial translocation in decompensated cirrhosis

Clees, C

Presence of sarcopenia is associated with development of acute-on-chronic liver failure in the NEPTUN cohort

Conrad, C

Clearance of chronic HCV infection leads to an expansion of a follicular T helper cell memory phenotype in HCV-specific CD4 T cells
Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis

Conrad, R

Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are markers for biliary damage and predict graft survival

Cornberg, M

Characterization of immune cells in patients with liver cirrhosis with and without spontaneous bacterial peritonitis
Impact of HBsAg on HBV-specific immune responses in HBeAg negative patients with chronic hepatitis B
High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)

Coskun, Ü

The RNA binding protein HuR is a master regulator of hepatic-lipid homeostasis

Cosma, LS

Delirium – of outstanding relevance for the interprofessional team on an intensive care unit with focus on hepatology

Cramer, T

An unexpected protective role for macrophages during hepatocellular carcinoma-associated cachexia

Cubero, FJ

Lack of Cyclin E1 aggravates ethanol-induced liver injury and hepatic steatosis in the murine model of acute ALD
c-MYC overexpression in hepatocytes is associated with spontaneous development of non-alcoholic steatohepatitis (NASH) in mice
Combined function of c-Jun N-terminal kinases in hepatocytes protects mice from fibrosis development during cholestatic liver injury
Intestinal dysbiosis drives liver disease progression via NLRP3 in the Mdr2-/- model of primary sclerosing cholangitis
Hepatocytic c-Jun N-terminal kinases (JNK) protect against cystogenesis in NEMO-deficient mice
Modulation of hepatocyte-specific c-Jun N-terminal kinase 2 (JNK2) during chronic liver disease using gene silencing

Czauderna, C

Exploring molecular basis of therapy response in patient derived primary liver cancer cell lines
Landscape of (epi-)genetic alterations during malignant transformation in liver cancer